IMNM
(NASDAQ)Immunome, Inc.
$21.99-- (--)
Loading... - Market loading
Immunome (IMNM) Stock Price & Financial Analysis
Immunome Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$21.83 - $22.66
52-Week High$27.65
52-Week Low$8.67
Open$22.32
Volume1.30M
Average Volume (3M)1.64M
Market Cap2.49B
Shares Outstanding113.14M
Price to Sales (P/S)619.65
Price to Book (P/B)4.23
EV/EBITDA-8.40
Revenue (TTM)4.01M
Net Income (TTM)-224.59M
Free Cash Flow (TTM)-205.52M
EPS (TTM)$-2.39
Profit Margin-5593.85%
Operating Margin-5947.90%
Return on Equity (ROE)-38.15%
Debt to Equity0.01
50-Day MA$21.05
200-Day MA$20.70
52-Week Change92.05%
Annual Dividend$0.00
Dividend Yield0.00%
Day's Range$21.83 - $22.66
52-Week High$27.65
52-Week Low$8.67
Open$22.32
Volume1.30M
Average Volume (3M)1.64M
Market Cap2.49B
Shares Outstanding113.14M
Price to Sales (P/S)619.65
Price to Book (P/B)4.23
EV/EBITDA-8.40
Revenue (TTM)4.01M
Net Income (TTM)-224.59M
Free Cash Flow (TTM)-205.52M
EPS (TTM)$-2.39
Profit Margin-5593.85%
Operating Margin-5947.90%
Return on Equity (ROE)-38.15%
Debt to Equity0.01
50-Day MA$21.05
200-Day MA$20.70
52-Week Change92.05%
Annual Dividend$0.00
Dividend Yield0.00%
Frequently Asked Questions About Immunome
What is the current stock price for IMNM?
As of the latest trading session, IMNM stock trades at $21.99. The 52-week range is $8.67–$27.65, with a day range of $21.83–$22.66.
What is the P/E ratio for IMNM?
The P/E ratio (Price-to-Earnings) for IMNM is shown in the Key Statistics section. This valuation metric helps compare Immunome, Inc. to industry peers.
Does IMNM pay dividends?
Immunome does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for IMNM?
Based on 15 analysts, the consensus for IMNM is Buy.
What is the market cap of IMNM?
Immunome's market capitalization is $2.49B, classifying it as a mid-cap company. Immunome operates in the Healthcare sector within the Biotechnology industry.